{
    "id": 26524,
    "fullName": "PIK3R1 R557_K561delinsQ",
    "impact": "indel",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PIK3R1 R557_K561delinsQ results in a deletion of five amino acids in the Pik3r1 protein from amino acids 557 to 561, combined with the insertion of a Glutamine (Q) at the same location (UniProt.org). R557_K561delinsQ has been identified in sequencing studies (PMID: 25157968), but has not been biochemically characterized and therefore, its effect on Pik3r1 protein function is unknown (PubMed, Nov 2019).",
            "references": [
                {
                    "id": 7996,
                    "pubMedId": 25157968,
                    "title": "Prospective enterprise-level molecular genotyping of a cohort of cancer patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25157968"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5295,
        "geneSymbol": "PIK3R1",
        "terms": [
            "PIK3R1",
            "AGM7",
            "GRB1",
            "IMD36",
            "p85",
            "p85-ALPHA"
        ]
    },
    "variant": "R557_K561delinsQ",
    "createDate": "05/04/2017",
    "updateDate": "12/06/2019",
    "referenceTranscriptCoordinates": {
        "id": 157926,
        "transcript": "NM_181523",
        "gDna": "chr5:g.68295249_68295260del12",
        "cDna": "c.1670_1681del12",
        "protein": "p.R557_K561delinsQ",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10771,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of BGJ398 and Alpelisib (BYL719) resulted in a synergistic effect, demonstrating inhibition of cell proliferation, decreased colony formation, and cell death in an endometrial cancer cell line harboring FGFR2 K310R and N550K, PIK3R1 R557_K561delinsQ, and PTEN R130fs in culture, and tumor regression in xenograft models (PMID: 28119489).",
            "molecularProfile": {
                "id": 27769,
                "profileName": "FGFR2 K310R FGFR2 N550K PIK3R1 R557_K561delinsQ PTEN R130fs"
            },
            "therapy": {
                "id": 1293,
                "therapyName": "Alpelisib + BGJ398",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8811,
                    "pubMedId": 28119489,
                    "title": "PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28119489"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10770,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of BGJ398 and Buparlisib (BKM120) resulted in a synergistic effect, demonstrating inhibition of cell proliferation, decreased colony formation, and induced cell death in an endometrial cancer cell line harboring FGFR2 K310R and N550K, PIK3R1 R557_K561delinsQ, and PTEN R130fs in culture (PMID: 28119489).",
            "molecularProfile": {
                "id": 27769,
                "profileName": "FGFR2 K310R FGFR2 N550K PIK3R1 R557_K561delinsQ PTEN R130fs"
            },
            "therapy": {
                "id": 5612,
                "therapyName": "BGJ398 + Buparlisib",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8811,
                    "pubMedId": 28119489,
                    "title": "PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28119489"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10769,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of BGJ398 and Pictilisib (GDC-0941) resulted in a synergistic effect, demonstrating inhibition of cell proliferation, decreased colony formation, and cell death in an endometrial cancer cell line harboring FGFR2 K310R and N550K, PIK3R1 R557_K561delinsQ, and PTEN R130fs in culture, and tumor regression in xenograft models (PMID: 28119489).",
            "molecularProfile": {
                "id": 27769,
                "profileName": "FGFR2 K310R FGFR2 N550K PIK3R1 R557_K561delinsQ PTEN R130fs"
            },
            "therapy": {
                "id": 5613,
                "therapyName": "BGJ398 + Pictilisib",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8811,
                    "pubMedId": 28119489,
                    "title": "PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28119489"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19930,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, borussertib inhibited proliferation and AKT signaling and increased apoptosis in an endometrial cancer cell line harboring PIK3R1 R557_K561delinsQ and PTEN R130fs in culture (PMID: 30858154).",
            "molecularProfile": {
                "id": 34731,
                "profileName": "PIK3R1 R557_K561delinsQ PTEN R130fs"
            },
            "therapy": {
                "id": 9256,
                "therapyName": "Borussertib",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17595,
                    "pubMedId": 30858154,
                    "title": "Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30858154"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27763,
            "profileName": "PIK3R1 R557_K561delinsQ",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27769,
            "profileName": "FGFR2 K310R FGFR2 N550K PIK3R1 R557_K561delinsQ PTEN R130fs",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34731,
            "profileName": "PIK3R1 R557_K561delinsQ PTEN R130fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 157927,
            "transcript": "XM_017009585",
            "gDna": "chr5:g.68295249_68295260del12",
            "cDna": "c.1670_1681del12",
            "protein": "p.R557_K561delinsQ",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157926,
            "transcript": "NM_181523",
            "gDna": "chr5:g.68295249_68295260del12",
            "cDna": "c.1670_1681del12",
            "protein": "p.R557_K561delinsQ",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157925,
            "transcript": "XM_005248542",
            "gDna": "chr5:g.68295249_68295260del12",
            "cDna": "c.1670_1681del12",
            "protein": "p.R557_K561delinsQ",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}